科力遠(600478.SH):公司以自有礦生產的碳酸鋰成本相對較低,仍有利潤空間
格隆匯12月8日丨科力遠(600478.SH)12月8日在互動平台表示,市場上碳酸鋰價格持續走弱,但公司以自有礦生產的碳酸鋰成本相對較低,仍有利潤空間;碳酸鋰產能方面,公司首期一萬噸碳酸鋰產能於12月達產。為應對價格波動,公司正積極準備套期保值業務;同時,公司也在研發新型提鋰技術,待完成商業化應用驗證後,有助於降低未來生產成本。2023年,公司重要轉型項目均處於建設週期,明年待轉型業務穩定發展運營後,業績有望發力。關於定增項目,前期盡調工作已基本完成,公司將綜合考量市場環境和公司實際情況,擇機實施增發方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.